Novocure L T D

FDA Filings

This page includes the latest FDA filings for Novocure L T D. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

ENGLAND

NASDAQ

NVCR

DUNS 221472105

FDA Registration(s)

• Registration Number: 3009453079
• FEI Number: 3009453079
• Name: NOVOCURE LTD
• Owner & Operator: Novocure
• Contact Address: Topaz Bldg , 4th floor Matam Center; Haifa IL-Z Ha Zafon 31905 IL
• Official Correspondent:
  • Zoya Gurvich
  • 972-54-6947114-x
• US Agent:
  • Mike Ambrogi
  • Novocure
  • 603 5014280
  • mambrogi@novocure.com
• Registration Status: 1
• Initial Importer: N
• Registration Expiration: 2020-04-25
• Registration Address: Topaz Bldg., Matam Center ; Haifa Ha Zafon, 3190500 IL
• Establishment Type: Manufacture Medical Device

FDA Filings

Device Company	Device	Date
PMN H180002 | QGZ NOVOCURE LTD [Novocure]	NovoTTF?-100L System	2019-12-06
PMA P100034S021 Novocure, Ltd.	Optune System	2019-04-12
PMA P100034S022 Novocure, Ltd.	Optune System	2019-02-28
PMA P100034S019 Novocure, Ltd.	Optune System	2018-12-19
PMA P100034S018 Novocure, Ltd.	Optune	2018-11-30
PMA P100034S020 Novocure, Ltd.	Optune System	2018-10-19
PMN P100034 | NZK NOVOCURE LTD [Novocure]	NovoTTF-100A Treatment kit	2012-02-21
PMN P100034 | NZK NOVOCURE LTD [Novocure]	INE transducer array	2012-02-21
PMA P100034 Novocure, Ltd.	NOVOCURE LTD'S NOVOTTF-100A TREATMENT KIT	2011-04-08

Similar & Related FDA Registered Companies

• Novocure GmbHpark 6ch-6039 Root D4  PMA NumberP100034 Supplement NumberS029 Date Received02/14/2022 Decision Date05/10/2022 Product Code NZK  Advisory Committee Neurology Supplement Typenormal 180 Day Track Supplement Reason Change Design/components/specifications/material Expedited Review Granted? No
• NOVOCURE (ISRAEL) LTD

Related Finance Registrations

SEC

0001645113

NovoCure Ltd